🧪 Hypotheses

therapeutic 1.00

Metabolic Reprogramming to Reverse Senescence

🧬 SIRT1,PGC1A,NAMPT 🏥 N/A

✅ 0.90 ✨ 0.60 💥 0.82

# Metabolic Reprogramming to Reverse Senescence in Neurodegeneration: A Mechanistic Hypothesis...

unknown 0.94

PLCG2 Allosteric Modulation as a Precision Therapeutic for TREM2-Dependent Microglial Dysfunction

🧬 PLCG2 🏥 neurodegeneration

✅ 0.42 ✨ 0.85 💥 0.72

## Mechanistic Overview...

unknown 0.92

HK2-Dependent Metabolic Checkpoint as the Gatekeeper of DAM Transition

🧬 HK2 🏥 neurodegeneration

✅ 0.55 ✨ 0.80 💥 0.75

## Mechanistic Overview...

unknown 0.90

CSF1R Inhibition-Mediated Microglial Replacement as a State Transition Reset

🧬 CSF1R 🏥 neurodegeneration

✅ 0.55 ✨ 0.70 💥 0.75

## Mechanistic Overview...

unknown 0.89

Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Collapse

🧬 SLC16A1, SLC16A7, LDHA, PDHA1 🏥 neurodegeneration

✅ 0.70 ✨ 0.62 💥 0.68

## Mechanistic Overview...

therapeutic 0.89

H1: TREM2 Agonism to Redirect APOE4-Enhanced Microglia from Synapse Pruning to Amyloid Clearance

🧬 TREM2 🏥 neurodegeneration

✅ 0.82 ✨ 0.65 💥 0.75

## Mechanistic Overview...

unknown 0.89

TREM2-APOE Axis Dissociation for Selective DAM Activation

🧬 TREM2-APOE axis 🏥 neurodegeneration

✅ 0.35 ✨ 0.78 💥 0.68

## Mechanistic Overview...

mechanistic 0.88

Transcriptional Autophagy-Lysosome Coupling

🧬 FOXO1 🏥 neurodegeneration

✅ 0.75 ✨ 0.80 💥 0.78

## Mechanistic Overview...

unknown 0.86

TREM2 R47H Variant-Driven Metabolic Dysfunction as the Primary Trigger for Failed DAM Transition

🧬 NAMPT 🏥 neurodegeneration

✅ 0.50 ✨ 0.65 💥 0.75

## Mechanistic Overview...

combination 0.85

p38α Inhibitor and PRMT1 Activator Combination to Restore Physiological TDP-43 Phosphorylation-Methylation Balance

🧬 MAPK14/PRMT1 🏥 neurodegeneration

✅ 0.78 ✨ 0.65 💥 0.82

## Mechanistic Overview...

unknown 0.84

Hypothesis 7: SST-SST1R/Gamma Entrainment-Enhanced Astrocyte Secretome

🧬 SST, SSTR1, SSTR2 🏥 neurodegeneration

✅ 0.85 ✨ 0.72 💥 0.82

## Mechanistic Overview...

unknown 0.83

H6: Aberrant eIF2α Phosphorylation Creates Stalled Translation State

🧬 EIF2S1, EIF2AK3/PERK, PPP1R15B, EIF2B 🏥 neurodegeneration

✅ 0.92 ✨ 0.70 💥 0.90

## Mechanistic Overview...

mechanistic 0.82

Microglial AIM2 Inflammasome as the Primary Driver of TDP-43 Proteinopathy Neuroinflammation in ALS/FTD

🧬 AIM2, CASP1, IL1B, PYCARD, TARDBP 🏥 neurodegeneration

✅ 0.00 ✨ 0.00 💥 0.00

## Mechanistic Overview...

combination 0.82

HSPB1 Phosphorylation Mimetics to Promote Protective TDP-43 Liquid-Liquid Phase Separation

🧬 HSPB1 🏥 neurodegeneration

✅ 0.55 ✨ 0.72 💥 0.75

## Mechanistic Overview...

therapeutic 0.81

AMPK hypersensitivity in astrocytes creates enhanced mitochondrial rescue responses

🧬 PRKAA1 🏥 neurodegeneration

✅ 0.85 ✨ 0.80 💥 0.75

## Mechanistic Overview...

therapeutic 0.81

Neutrophil Extracellular Trap (NET) Inhibition

🧬 PADI4 🏥 N/A

✅ 0.00 ✨ 0.00 💥 0.00

## Mechanistic Overview...

therapeutic 0.80

Dual-Receptor Antibody Shuttling

🧬 N/A 🏥 Alzheimer's disease

✅ 0.00 ✨ 0.00 💥 0.00

## Mechanistic Overview...

mechanistic 0.80

Mitochondrial DNA-Driven AIM2 Inflammasome Activation in Neurodegeneration

🧬 AIM2, CASP1, IL1B, PYCARD 🏥 neurodegeneration

✅ 0.00 ✨ 0.00 💥 0.00

## Mechanistic Overview...

combination 0.80

CSF sTREM2 as Pharmacodynamic Biomarker for Therapeutic Window Identification

🧬 sTREM2/membrane-TREM2/ADAM10 🏥 neuroimmunology

✅ 0.85 ✨ 0.60 💥 0.88

## Mechanistic Overview...

unknown 0.80

pH-Sensitive Bispecific Antibody Targeting Transferrin Receptor for CNS Delivery

🧬 TFRC (TfR1); endosomal acidification pathway 🏥 neurodegeneration

✅ 0.78 ✨ 0.82 💥 0.88

## Mechanistic Overview...

unknown 0.80

Hypothesis 1: MANF/CDNF Signaling as Primary Neuroprotective Effector

🧬 MANF, CDNF 🏥 neurodegeneration

✅ 0.48 ✨ 0.68 💥 0.62

## Mechanistic Overview...

therapeutic 0.80

Microglial TREM2-SYK Pathway Enhancement

🧬 TREM2 🏥 neurodegeneration

✅ 0.70 ✨ 0.60 💥 0.80

## Mechanistic Overview...

mechanistic 0.79

Targeting SASP-Complement Amplification Through HIF-1α Downstream Effectors

🧬 C1QA, C1QB, C3, IL1B 🏥 neurodegeneration

✅ 0.78 ✨ 0.65 💥 0.75

## Mechanistic Overview...

therapeutic 0.79

VCP-Mediated Autophagy Enhancement

🧬 VCP 🏥 neurodegeneration

✅ 0.00 ✨ 0.00 💥 0.00

## Mechanistic Overview...

combination 0.78

Integrated Biomarker Panel for Therapeutic Window Identification

🧬 CHI3L1 🏥 neurodegeneration

✅ 0.78 ✨ 0.65 💥 0.70

## Mechanistic Overview...

mechanistic 0.78

SASP-Driven Aquaporin-4 Dysregulation

🧬 AQP4 🏥 neurodegeneration

✅ 0.60 ✨ 0.65 💥 0.72

## Mechanistic Overview...

combination 0.78

TREM2-mediated microglial tau clearance enhancement

🧬 TREM2 🏥 neurodegeneration

✅ 0.00 ✨ 0.00 💥 0.00

## Mechanistic Overview...

mechanistic 0.78

TFEB Nuclear Translocation to Reset Lysosomal-Hypoxia Axis

🧬 TFEB, MTOR 🏥 neurodegeneration

✅ 0.65 ✨ 0.70 💥 0.68

## Mechanistic Overview...

therapeutic 0.78

Selective HDAC3 Inhibition with Cognitive Enhancement

🧬 HDAC3 🏥 neurodegeneration

✅ 0.70 ✨ 0.85 💥 0.80

## Mechanistic Overview...

unknown 0.78

TBK1 Loss Locks Microglia in an Aged/Senescent Transcriptional State, Fueling ALS-Associated SASP

🧬 TBK1 → NF-κB / IRF3 / p62-autophagy / cGAS-STING axis 🏥 ALS

✅ 0.80 ✨ 0.82 💥 0.50